3Wollina U. Clinical management of pyoderma gangrenosum. Am J Cli. Dermato1,2002,3 (3) : 149-158.
4Reichrath J, Bens G, Bonowitz A, et al. Treatment recommen- dations for pyoderma gangrenosum: an evidence-based review of the literature based on more than 350 patients. J Am Acad Der-mato1,2005,53(2) :273-283.
1Engelkens GJ, Kate FJ, Vuzevski VD,et al.Primary and secondary syphilis: a histopathological study[J].Int J STD AIDS,1991,2 (4): 280-284.
2Salazar JC, Hazlett KR, Radolf JD.The immune response to infection with Treponema pallidum, the stealth pathogen[J].Microbes Infect, 2002, 4(11): 1133-1140.
3吴志华.现代皮肤性病学[M].广州：广东人民出版社,1999.338.
4von den Driesch P. Pyoderma gangrenosum: a report of 44 cases with follow-up[J]. Br J Dermatol, 1997, 137(6): 1000-1005.
5Gonzalgo ML, de Lacerda DA, De Marzo AM, et al. Persistent purulent drainage from the glans penis: atypical presentation of pyodenna gangrenosum[J]. J Urol, 2003, 169(5): 1793-1794.
6Brown TS, Marshall GS, Callen JP. Cavitating pulmonary infiltrate in an adolescent with pyoderma gan~enosum: a rarely recognized extracutaneous manifestation of a neutrophilic dermatosis[J]. J Am Acad Dermatol, 2000, 43(1 Pt 1): 108-112.
7Powell FC, Su WP, Perry HO. Pyodenna gangrenosum: classification and management[J]. J Am Acad Dennatol, 1996, 34(3):395-409.
8Bhat RM. Management of pyodenna gangrenosum - An update[J].Indian J Dennatol Venereol Leprol, 2004, 70(6): 329-335.
9Evans AV. The expanding role of topical tacrolimus in dermatology[J]. Clin Exp Dermatol, 2005, 30(2): 111-115.
10Schuppe HC, Homey B, Assmann T, et al. Topical tacrolimus for pyoderma gangrenosum[J]. Lancet, 1998, 351(9105): 832.
